Enhanced cellular immunity to SIV Gag following co-administration of adenoviruses encoding wild-type or mutant HIV Tat and SIV Gag

Virology. 2005 Nov 10;342(1):1-12. doi: 10.1016/j.virol.2005.07.016. Epub 2005 Aug 18.

Abstract

Among candidate antigens for human immunodeficiency virus (HIV) prophylactic vaccines, the regulatory protein Tat is a critical early target, but has a potential for immune suppression. Adenovirus (Ad) recombinants encoding wild-type HIV Tat (Tat-wt) and a transdominant negative mutant HIV Tat (Tat22) were constructed and administered to mice separately or together with Ad-SIVgag. Immunogenicity and effects on immune responses to the co-administered Gag immunogen were evaluated. Wild-type and mutant Tat recombinants elicited similar Tat-specific cellular and humoral immune responses. Co-administration of either Tat immunogen with Ad-SIVgag induced modest but significant enhancement of Gag-specific interferon-gamma secreting T cells and lymphoproliferative responses. Neither the Ad-recombinant encoding Tat-wt nor Tat22 suppressed induction of anti-Tat or anti-Gag antibodies. Based on the immune responses observed in mice, both recombinants appear to be suitable vaccine candidates. Their contribution to protective efficacy remains to be determined in a non-human primate model.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS Vaccines / administration & dosage
  • AIDS Vaccines / genetics
  • AIDS Vaccines / immunology
  • Adenoviridae / genetics
  • Adenoviridae / immunology
  • Animals
  • Antibodies, Viral / biosynthesis
  • Base Sequence
  • DNA, Recombinant / genetics
  • Female
  • Gene Products, gag / genetics*
  • Gene Products, gag / immunology*
  • Gene Products, tat / genetics*
  • Gene Products, tat / immunology*
  • Genes, gag
  • Genes, tat
  • Genetic Vectors
  • HIV Antibodies / biosynthesis
  • HIV-1 / genetics*
  • HIV-1 / immunology*
  • Humans
  • Immunity, Cellular
  • Immunization
  • Interferon-gamma / biosynthesis
  • Macaca mulatta
  • Mice
  • Mice, Inbred BALB C
  • Mutation
  • Simian Immunodeficiency Virus / genetics*
  • Simian Immunodeficiency Virus / immunology*
  • T-Lymphocytes / immunology
  • Vaccines, Synthetic / administration & dosage
  • Vaccines, Synthetic / genetics
  • Vaccines, Synthetic / immunology
  • tat Gene Products, Human Immunodeficiency Virus

Substances

  • AIDS Vaccines
  • Antibodies, Viral
  • DNA, Recombinant
  • Gag protein p27, Simian immunodeficiency virus
  • Gene Products, gag
  • Gene Products, tat
  • HIV Antibodies
  • Vaccines, Synthetic
  • tat Gene Products, Human Immunodeficiency Virus
  • Interferon-gamma